APA (7th ed.) Citation

Angelicola, S., Giunchi, F., Ruzzi, F., Frascino, M., Pitzalis, M., Scalambra, L., . . . Palladini, A. (2025). PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD). Journal of translational medicine, 23(1), 2-20. https://doi.org/10.1186/s12967-024-06023-8

Chicago Style (17th ed.) Citation

Angelicola, Stefania, et al. "PD-L1 and IFN-γ Modulate Non-Small Cell Lung Cancer (NSCLC) Cell Plasticity Associated to Immune Checkpoint Inhibitor (ICI)-mediated Hyperprogressive Disease (HPD)." Journal of Translational Medicine 23, no. 1 (2025): 2-20. https://doi.org/10.1186/s12967-024-06023-8.

MLA (9th ed.) Citation

Angelicola, Stefania, et al. "PD-L1 and IFN-γ Modulate Non-Small Cell Lung Cancer (NSCLC) Cell Plasticity Associated to Immune Checkpoint Inhibitor (ICI)-mediated Hyperprogressive Disease (HPD)." Journal of Translational Medicine, vol. 23, no. 1, 2025, pp. 2-20, https://doi.org/10.1186/s12967-024-06023-8.